LPL Financial Welcomes Advisor John Somerville to Linsco Channel
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor John Somerville has joined […]
Atossa Therapeutics Applauds U.S. Surgeon General’s Advisory Highlighting Alcohol as a Leading Preventable Cause of Breast Cancer
SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company […]
ABITS GROUP DOUBLES CAPACITY TO 22MW
Hong Kong, Jan. 06, 2025 (GLOBE NEWSWIRE) — Abits Group Inc. (NASDAQ: ABTS), a U.S.-based digital data center operator specializing […]
Davis Commodities Limited Announces USD 2 million AI Operation Enhancement MOU with QBE.AI Limited
SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) — Singapore-based Davis Commodities Limited (NASDAQ: DTCK), a leading global agricultural commodity trading company, […]
Senti Bio Announces Additional $11.5 Million of Financing
– Approximately $10 million additional investment in private placement equity financing – – $1.5 million from CIRM grant first announced […]
Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced […]
ibex Appoints Karen Batungbacal to Board of Directors
WASHINGTON, Jan. 06, 2025 (GLOBE NEWSWIRE) — IBEX Limited (“ibex”), a leading provider in global business process outsourcing and end-to-end […]
ARRAY Technologies Names Darin Green as Chief Revenue Officer for North America
ALBUQUERQUE, N.M., Jan. 06, 2025 (GLOBE NEWSWIRE) — ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading provider of […]
Alpha Modus Secures 9th AI Patent, Strengthening Leadership in Retail Innovation
CORNELIUS, N.C., Jan. 06, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Alpha Modus” or the “Company”), announces […]
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused […]
